Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Geriatric Assessment and Promotores (GAP) Pilot Feasibility Study [NA]
Completed pilot feasibility trial evaluating the Geriatric Assessment and Promotores (GAP) program in cancer care.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer [Phase 3]
A Phase 3 clinical trial evaluating SKB264 for locally advanced, recurrent or metastatic HR+/HER2- breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Minimal Residual Disease in Solid Malignancies [NA]
This clinical trial update describes a study evaluating minimal residual disease in solid malignancies across several cancers, and it is cur…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Omission of Axillary Lymph Node Dissection in Case of Tumor Spread to Lymph Nodes in the Armpit in Breast Cancer [NA]
A clinical trial update describes evaluating the omission of axillary lymph node dissection in breast cancer patients with lymph node involv…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: The Study Will Enroll Females Who Are Coming in for Their Annual Mammogram Screening and Who Are Schedule for a Biopsy to Provide a Breath Sample Via a Mask to Evaluate if Breast Cancer Can be Detected.
A clinical trial will enroll women undergoing annual mammograms and scheduled biopsies to evaluate a breath-sampling mask for detecting brea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV) [NA]
This clinical trial update reports completion and results posting for a study evaluating intraoperative acupoint stimulation to prevent post…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer [NA]
A clinical trial is studying whether a controlled low-calorie diet can reduce chemotherapy side effects and improve treatment response in pa…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors [Phase 2]
Phase 2 clinical trial is evaluating phytocannabinoids for reducing chemotherapy-induced peripheral neuropathy in breast and colon cancer su…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer [NA]
A completed Mayo Clinic trial comparing Quantitative Transmission Imaging with MRI as a supplemental screening tool for women at high lifeti…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer [NA]
A completed clinical trial from XEOS Medical evaluating specimen PET-CT imaging for intraoperative margin assessment in breast cancer. The s…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia
A prospective non-interventional study in Russia evaluates clinical outcomes of Ribociclib (Risarg) combined with endocrine therapy or chemo…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.
This clinical trial evaluates whether high-resolution PET-CT imaging with the XEOS AURA 10 correlates with histopathology and long-term outc…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Treatment Pathway of Patients Suffering From a Breast Cancer Related Lymphoedema [NA]
The document reports the completion of a clinical trial conducted by University Hospital, Toulouse, examining a treatment pathway for breast…
-
CLINICAL_TRIALS other · 2025-12-05Clinical Trial Update: Clinical Study to Evaluate Debio0123 + Sacituzumab Govitecan Combination in TNBC or HR+/HER2- Advanced Breast Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Debio0123 in combination with sacituzumab govitecan for advanced breast cancer (TNBC or HR+/HER2-); stud…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy [Phase 2]
Open-label Bayesian adaptive Phase II clinical study in HR+/HER2- advanced breast cancer after progression on standard therapy; sponsored by…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer [Phase 1, Phase 2]
A clinical trial evaluating ivermectin in combination with balstilimab or pembrolizumab for metastatic triple-negative breast cancer, in Pha…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Evaluation of the Added Value of Logotherapy in the Psychological Support of Patients With Primary Breast Cancer [NA]
A clinical trial evaluating the added value of logotherapy in the psychological support of patients with primary breast cancer; the study is…
-
CLINICAL_TRIALS other · 2025-12-05Clinical Trial Update: Long Term Follow-Up in Patients With Stage 0-IIIC Breast Cancer
Clinical trial update describing long-term follow-up in patients with breast cancer (stage 0 to IIIC). The study is currently active but not…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED [Phase 2]
A Phase 2 trial (PRIMED) evaluating a preventive strategy for IMMU132-related adverse events in triple-negative and HR+/HER2-negative breast…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens.
This clinical trial update describes the evaluation of tucatinib in patients with locally advanced or metastatic HER2-positive breast cancer…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases [Phase 1]
Phase 1 clinical trial evaluating the combination of stereotactic radiation and nivolumab for metastatic breast cancer with brain metastases…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction [Phase 2]
This Phase 2 clinical trial aims to evaluate neurotization of the nipple-areolar complex to restore sensation in breast cancer patients unde…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting
A real-world study of alpelisib in combination with fulvestrant for HR-positive, HER2-negative, PIK3CA-mutant breast cancer has been termina…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Deep Learning Method to Evaluate QT on Ribociclib
A completed study evaluating a deep learning approach to assess the QT interval effects of ribociclib in breast cancer.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer [Phase 2]
A Phase 2 clinical trial is investigating sequential therapies designed around evolutionary dynamics for metastatic breast cancer. The study…